Evidence map›Paper›PMID 23375933›Full record

ArticleJournal of the American College of Cardiology2013

Treatment differences by health insurance among outpatients with coronary artery disease: insights from the national cardiovascular data registry.

Kim G Smolderen, John A Spertus, Fengming Tang, William Oetgen, William B Borden, Henry H Ting, Paul S Chan

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
16.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Have health insurance reforms in Tunisia attained their intended objectives?International journal of health economics and management · 2015
    Article
  20. Finding medical care for colorectal cancer symptoms: experiences among those facing financial barriers.Health education & behavior : the official publication of the Society for Public Health Education · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Kim G SmolderenSaint Luke's Mid America Heart Institute, Kansas City, Missouri 64111, USA.
John A Spertus
Fengming Tang
William Oetgen
William B Borden
Henry H Ting
Paul S Chan
Saint Luke's Hospital · USAmerican College of Cardiology · USCornell University · USMayo Clinic · USTilburg University · NL

Funding

The Appropriateness Criteria for Coronary Revascularization: Feasibility of MeasuK23HL102224 · NHLBI · SAINT LUKE'S HOSPITAL · PI CHAN, PAUL SHEUNG-YAN · 2010 to 2014
$610k
NHLBI NIH HHS K23 HL102224
6 · The paper itself

Abstract

objectivesThis study examined the association between insurance status and physicians' adherence with providing evidence-based treatments for coronary artery disease (CAD).

methodsWithin the PINNACLE (Practice Innovation and Clinical Excellence) registry of the NCDR (National Cardiovascular Data Registry), the authors identified 60,814 outpatients with CAD from 30 U.S. practices. Hierarchical modified Poisson regression models with practice site as a random effect were used to study the association between health insurance (no insurance, public, or private health insurance) and 5 CAD quality measures.

resultsOf 60,814 patients, 5716 patients (9.4%) were uninsured and 11,962 patients (19.7%) had public insurance, whereas 43,136 (70.9%) were privately insured. After accounting for exclusions, uninsured patients with CAD were 9%, 12%, and 6% less likely to receive treatment with a beta-blocker, an angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker (ACE-I/ARB), and lipid-lowering therapy, respectively, than privately insured patients, and patients with public insurance were 9% less likely to be prescribed ACE-I/ARB therapy. Most differences by insurance status were attenuated after adjusting for the site providing care. For example, whereas uninsured patients with left ventricular dysfunction and CAD were less likely to receive ACE-I/ARB therapy (unadjusted RR: 0.88; 95% CI: 0.84 to 0.93), this difference was eliminated after adjustment for site (adjusted RR: 0.95; 95% CI: 0.88 to 1.03; p = 0.18).

conclusionsWithin this national outpatient cardiac registry, uninsured patients were less likely to receive evidence-based medications for CAD. These disparities were explained by the site providing care. Efforts to reduce treatment differences by insurance status among cardiac outpatients may additionally need to focus on improving the rates of evidence-based treatment at sites with high proportions of uninsured patients.

Indexed as

Adrenergic beta-AntagonistsAmbulatory CareAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCoronary Artery DiseaseDrug UtilizationFemaleHumansHypolipidemic AgentsInsurance, HealthMaleMedicaidMedically UninsuredMedicareMiddle AgedPlatelet Aggregation InhibitorsAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsHypolipidemic AgentsPlatelet Aggregation Inhibitors

Identifiers

PMID23375933
PMCPMC3641586
OpenAlexW121227233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.